OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation TechCrunch By: Lucas Ropek 15 December 2025 at 18:41 Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.